Ikena Oncology (IKNA)
NASDAQ:IKNA
US Market
Holding IKNA?
Track your performance easily

Ikena Oncology (IKNA) Financial Statements

93 Followers

Ikena Oncology Financial Overview

Ikena Oncology's market cap is currently ―. The company's EPS TTM is $-1.426; its P/E ratio is -1.16; Ikena Oncology is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ 659.00K$ 1.19M$ 2.00M
Gross Profit--$ 658.00K$ 1.19M$ 2.00M
EBIT$ -13.67M$ -15.64M$ -21.91M$ -17.34M$ -17.11M
EBITDA$ -13.18M$ -15.43M$ -21.60M--
Net Income Common Stockholders$ -13.73M$ -16.15M$ -19.49M$ -17.34M$ -17.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 145.42M$ 157.35M$ 175.47M$ 196.93M$ 157.31M
Total Assets$ 157.49M$ 172.78M$ 192.09M$ 215.34M$ 171.76M
Total Debt$ 9.09M$ 9.74M$ 11.69M$ 12.34M$ 4.99M
Net Debt$ -136.33M$ -147.60M$ -163.78M$ -184.59M$ -152.32M
Total Liabilities$ 14.63M$ 17.43M$ 22.34M$ 28.15M$ 15.06M
Stockholders Equity$ 142.86M$ 155.35M$ 169.76M$ 155.34M$ 156.70M
Cash Flow-
Free Cash Flow$ -12.32M$ -18.24M$ -22.09M--
Operating Cash Flow$ -12.50M$ -18.30M$ -21.82M$ -20.00M-
Investing Cash Flow$ 3.92M$ -48.74M$ 20.38M$ 31.89M-
Financing Cash Flow--$ 60.00K$ 38.92M-
Currency in USD

Ikena Oncology Earnings and Revenue History

Ikena Oncology Debt to Assets

Ikena Oncology Cash Flow

Ikena Oncology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis